These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5162259)

  • 21. [Vaccination against measles].
    Ek E
    Tidsskr Nor Laegeforen; 1971 Jan; 91(2):135-7. PubMed ID: 5539605
    [No Abstract]   [Full Text] [Related]  

  • 22. [Persistence of antibodies after vaccination against measles (author's transl)].
    Sejda J; Strauss J; Pecenka J; Strnad P
    Cesk Epidemiol Mikrobiol Imunol; 1977 Mar; 26(2):76-82. PubMed ID: 141341
    [No Abstract]   [Full Text] [Related]  

  • 23. [Trials of vaccination against measles with live and attenuated virus].
    Albano A; De Donato S; Nodari R; Criscuolo A
    G Mal Infett Parassit; 1967 Oct; 19(10):631-8. PubMed ID: 5611500
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys.
    Nigatu W; Samuel D; Cohen B; Cumberland P; Lemma E; Brown DW; Nokes J
    Vaccine; 2008 Sep; 26(37):4769-74. PubMed ID: 18644417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Humoral response against measles in children 7 years following vaccination].
    Wroczyńska-Palka M; Morzycka M; Chrapowicki T; Krauze-Kancewicz B
    Pol Tyg Lek; 1976 Jun; 31(24):1017-20. PubMed ID: 951270
    [No Abstract]   [Full Text] [Related]  

  • 26. [An investigation of the sero-epidemiological effect of emergent vaccination with measles vaccine].
    Zhang RZ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1987 Oct; 8(5):288-90. PubMed ID: 3449217
    [No Abstract]   [Full Text] [Related]  

  • 27. [New methods on the measles prophylaxis (author's transl)].
    de Blasi R; Fazio-Gentile G
    Ann Sclavo; 1979; 21(2):113-59. PubMed ID: 485597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rural Kenya: measles during pregnancy and early infancy.
    Arya SC; Agarwal N
    J Infect Dis; 2006 Jan; 193(1):165-6; author reply 166-7. PubMed ID: 16323147
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pattern of susceptibility to measles in Italy. Serological Study Group.
    Salmaso S; Gabutti G; Rota MC; Giordano C; Penna C; Mandolini D; Crovari P
    Bull World Health Organ; 2000; 78(8):950-5. PubMed ID: 10994277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
    Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
    Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Live measles vaccine prepared in dog kidney cells. 3. Vaccination against measles with Czechoslovak live vaccine.
    Adam E; Kratochvílova M; Mares I; Drevo M; Závadová H
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(2):232-9. PubMed ID: 5330077
    [No Abstract]   [Full Text] [Related]  

  • 34. Measles IgA in the nasal washings of adult volunteers and children immunized intranasally with measles vaccine L-16.
    Liashenko VA; Krasnova VP; Youminova NV
    Hum Antibodies; 1999; 9(3):143-8. PubMed ID: 10690626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevalence of antibodies against the rubeola virus in an isolated Indian community, north of Para, Brazil].
    Linhares AC; Macêdo O; Santos EO
    Rev Latinoam Microbiol; 1983; 25(2):131-6. PubMed ID: 6658236
    [No Abstract]   [Full Text] [Related]  

  • 36. [Serological methods of detecting antibodies against the measles virus: use of the ELISA immunoenzyme technic].
    Rapicetta M; Proietti E; Morace G; Rozera C; Macchia T
    Ann Ist Super Sanita; 1982; 18(3):525-8. PubMed ID: 7187839
    [No Abstract]   [Full Text] [Related]  

  • 37. [Anti-measles vaccination with inactivated virus].
    Terragna A; Roscioli B; De Marco B
    G Mal Infett Parassit; 1967 Apr; 19(4):219-22. PubMed ID: 5614197
    [No Abstract]   [Full Text] [Related]  

  • 38. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination.
    Ueda K; Hashiguchi K; Nakashima F; Ueda S; Takahashi M
    Biken J; 1981 Sep; 24(3):119-22. PubMed ID: 7337678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.